Skadi Stahlberg

No ORCID on file · 6 papers in corpus
article 2011
·doi:10.1016/j.contraception.2011.01.002

BackgroundThe present study compared the efficacy and safety of a combined oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest (EE/DNG) in conventional and extended-cycle regimen over 1 year of treatment.Study designIn …

article 2010
·doi:10.1055/s-0030-1248263

The effects of extended regimens of combined oral contraceptives (COCs) on carbohydrate metabolism are largely unknown. The present study compared the effects of a COC containing 30 microg ethinylestradiol and 2 mg dienogest (EE/DNG) in con…

article 2009
·doi:10.1016/j.contraception.2009.07.011

BackgroundThe effects of extended regimens of combined oral contraceptives (COC) on lipid parameters are largely unknown. The present study compared the effects of a COC containing 30 mcg ethinyl estradiol and 2 mg dienogest (EE/DNG) in con…

article 2008
·doi:10.1016/j.contraception.2008.02.005

BackgroundThis study was conducted to investigate the effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on thyroid hormones and androgen parameters.Study designThyroid and androgen parameters were measu…

article 2008
·doi:10.1016/j.contraception.2008.06.015

BackgroundThe study was conducted to investigate the effect of a combined oral contraceptive (COC) containing 30 mcg ethinylestradiol and 2 mg dienogest with two different regimens on various hemostasis variables.Study designHemostatic para…

article 2006
·doi:10.1055/s-2006-952281

In einer prospektiven, randomisierten, multizentrischen Studie wurden insgesamt 1315 Frauen im Alter zwischen 18 und 40 Jahren mit 30µg Ethinylestradiol + 2mg Dienogest entweder für 13 konventionelle (21 Tabletten) oder 4 Langzyklen (84 Tab…